跳至主要内容
临床试验/NCT04192656
NCT04192656招募中4 期

The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study

Beijing Tsinghua Chang Gung Hospital1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2019年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
102
试验地点
1
主要终点
hearing threshold

研究概览

简要总结

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged >= 18 and <= 70,
  • diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI > 15/h,
  • diagnosed with ISSHL by AAO-HNS 2019 criteria,
  • ISSHL onset within 1 week.

排除标准

  • sudden hearing loss with certain causes,
  • with severe comorbid diseases,
  • pregnant or breast-feeding women,
  • AHI <= 15/h,
  • hearing threshold recovered > 50% when included,
  • previously regularly treated with PAP.

研究组 & 干预措施

medication

Active Comparator

patients treated by medication only

干预措施: Ginaton (Drug)

PAP plus medication

Experimental

patients treated by both PAP and medication

干预措施: non-invasive positive airway pressure (Device)

PAP plus medication

Experimental

patients treated by both PAP and medication

干预措施: Methylprednisolone Hemisuccinate (Drug)

PAP plus medication

Experimental

patients treated by both PAP and medication

干预措施: Ginaton (Drug)

medication

Active Comparator

patients treated by medication only

干预措施: Methylprednisolone Hemisuccinate (Drug)

结局指标

主要结局

hearing threshold

时间窗: 3 months after onset of ISSHL

the recovery of hearing threshold which will be measured by pure tone audiometry

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ye Jingying

Director of the dept. of Otolaryngology, Head and Neck Surgery, and Director of the Center of Sleep Medicine

Beijing Tsinghua Chang Gung Hospital

研究点 (1)

Loading locations...

相似试验